Keyphrases
Biological Specimens
16%
Cardiovascular Complications
100%
Clinical High Risk
16%
Clinically Significant
16%
Complex Heterogeneity
23%
Coronavirus
16%
CoV-2
16%
COVID-19
66%
Diagnostic Progression
23%
Disease Progression
16%
Diverse Populations
16%
End Organ
33%
Infection Biomarkers
6%
Infection Severity
76%
Inflammation
16%
Inflammatory Biomarkers
66%
Integrated EHR
6%
Intense Monitoring
23%
Intensive Monitoring
6%
Metabolic Biomarkers
100%
Metabolism
16%
Molecular Mechanism
33%
North Carolina
16%
Novel COVID-19
23%
Novel Therapeutics
16%
Omics Data
6%
Organ Complications
33%
Patients with COVID-19
23%
Predictors of Infection
23%
Progression Biomarkers
16%
Racial Differences
16%
Risk Factors
16%
SARS-CoV-2 Infection
50%
Sensory Analysis
23%
Therapeutic Intervention
16%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cardiovascular Disease
100%
Coronavirinae
15%
Disease Exacerbation
15%
Infection
100%
Inflammation
15%
SARS Coronavirus
100%
Severe Acute Respiratory Syndrome
36%
Tamsulosin
15%
Medicine and Dentistry
Biological Marker
66%
Cardiovascular Disease
66%
Cardiovascular System
11%
Coronavirinae
11%
COVID-19
22%
Diagnosis
11%
Disease Exacerbation
15%
Infection
66%
Race Difference
11%
Severe Acute Respiratory Syndrome
22%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Specimen
11%
Tamsulosin
11%